Body composition in young adult survivors of childhood acute lymphoblastic leukaemia

被引:89
作者
Jarfelt, M [1 ]
Lannering, B
Bosaeus, I
Johannsson, G
Bjarnason, R
机构
[1] Univ Gothenburg, Dept Pediat, Div Haematol & Oncol, Gothenburg, Sweden
[2] Univ Gothenburg, Goteborg Paediat Growth Res Ctr, Gothenburg, Sweden
[3] Univ Gothenburg, Dept Clin Nutr, Gothenburg, Sweden
[4] Univ Gothenburg, Res Ctr Endocrinol & Metab, Sahlgrenska Acad, Gothenburg, Sweden
[5] Landspitali Univ Hosp, Dept Pediat, Reykjavik, Iceland
关键词
D O I
10.1530/eje.1.01931
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective: Obesity is frequently reported in patients treated for childhood leukaemia. Obesity, particularly abdominal obesity, is one of the main characteristics of the metabolic syndrome and a risk factor for cardiovascular disease and non-insulin-dependent diabetes mellitus (NIDDM). Design: All patients treated for acute lymphoblastic leukaemia (ALL) before the onset of puberty in the region of western Sweden, between 1973 and 1985, and in first remission, were included. 35 out of 47 patients aged 20-32 years participated. 19 patients had received cranial radiotherapy, and the median follow-up time was 20 years. The focus of this report was to study body composition and signs of the metabolic syndrome and correlate the findings to spontaneous growth hormone (GH) secretion. Methods: Body composition was assessed using dual-energy X-ray absorbtiometry (DEXA). We analyzed serum concentrations of insulin, glucose, leptin and lipids. Results: No patient was obese according to World Health Organization criteria (body mass index, BMI >= 30 kg/m(2)) but one-third were overweight (BMI 25-29.9 kg/m(2)). The maximal GH peak during 24 h (GH(max)) was correlated to percentage of total body fat (r = - 0.42; P = 0.017), trunk fat (r = - 0.5; P = 0.005) and fat-free mass (r = 0.42; P = 0.017). GH(max) was also correlated to s-triglycerides (r = - 0.54; P = 0.001), low-density lipoprotein-cholesterol (r = 0.382; P = 0.024) and high-density lipoprotein-cholesterol (r = 0.45: P = 0.007). Conclusions: We found little effect on BMI but an increased percentage of total body fat, especially trunk fat, and a tendency for an unfavourable lipid profile in adult survivors of childhood leukaemia. These findings were related to low endogenous GH secretion due to cranial irradiation.
引用
收藏
页码:81 / 89
页数:9
相关论文
共 43 条
[1]
[Anonymous], ACTA PAEDIAT S
[2]
[Anonymous], PERMUTATION TEST
[3]
Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia [J].
Birkebæk, NH ;
Clausen, N .
ARCHIVES OF DISEASE IN CHILDHOOD, 1998, 79 (02) :161-164
[4]
Body fat distribution, insulin resistance, and metabolic diseases [J].
Bjorntorp, P .
NUTRITION, 1997, 13 (09) :795-803
[5]
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[6]
Brennan BMD, 1999, CLIN ENDOCRINOL, V50, P163
[7]
Brennan BMD, 1998, CLIN ENDOCRINOL, V48, P777
[8]
Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment [J].
Bülow, B ;
Link, K ;
Ahrén, B ;
Nilsson, AS ;
Erfurth, EM .
CLINICAL ENDOCRINOLOGY, 2004, 61 (06) :683-691
[9]
Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors [J].
Clasey, JL ;
Weltman, A ;
Patrie, J ;
Weltman, JY ;
Pezzoli, S ;
Bouchard, C ;
Thorner, MO ;
Hartman, ML .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3845-3852
[10]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497